Key point: Several newer antiseizure medications, including the most recent, cenobamate, are now available for the treatment of focal epilepsy.
doi.org/10.1111/epi....

#epilepsy #ILAE #Cenobamate #SKlifescience #antiseizuremedications #drugresistantepilepsy #focalepilepsy

Key point: Evidence supports the consideration of cenobamate earlier in the treatment regimen and suggests a potential new benchmark for ASM treatment.
doi.org/10.1111/epi....

#epilepsy #ILAE #Cenobamate #SKlifescience #antiseizuremedications #epilepsyinolderpatients #pediatricepilepsy

Key point: Tolerability is an essential component of the overall effectiveness of antiseizure medications.
doi.org/10.1111/epi....

#epilepsy #ILAE #Cenobamate #SKlifescience #drugdruginteractions #titration #tolerability

Key point: Seizure freedom has been a goal of epilepsy treatment for >25 years, but rates of seizure freedom have changed little during this time.
doi.org/10.1111/epi....

#epilepsy #ILAE # Cenobamate #SKlifescience #focalepilepsy #seizurefreedom

Do the third-generation antiseizure medications provide the “magic bullet” for drug-resistant epilepsy? Focus on cenobamate
doi.org/10.1111/epi....

#epilepsy #ILAE # Cenobamate #SKlifescience